0001213900-18-002859.txt : 20180313 0001213900-18-002859.hdr.sgml : 20180313 20180312191021 ACCESSION NUMBER: 0001213900-18-002859 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180313 DATE AS OF CHANGE: 20180312 EFFECTIVENESS DATE: 20180313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADIAL PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001513525 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 800667150 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-307524 FILM NUMBER: 18684857 BUSINESS ADDRESS: STREET 1: 1180 SEMINOLE TRAIL STREET 2: SUITE 495 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 BUSINESS PHONE: 434-422-9800 MAIL ADDRESS: STREET 1: 1180 SEMINOLE TRAIL STREET 2: SUITE 495 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 FORMER COMPANY: FORMER CONFORMED NAME: ADial Pharmaceuticals, L.L.C. DATE OF NAME CHANGE: 20170515 FORMER COMPANY: FORMER CONFORMED NAME: Adial Pharmaceuticals, L.L.C. DATE OF NAME CHANGE: 20110218 D 1 primary_doc.xml X0708 D LIVE 0001513525 ADIAL PHARMACEUTICALS, INC. 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA VIRGINIA 22902 434-422-9800 DELAWARE Adial Pharmaceuticals L.L.C. ADial Pharmaceuticals, L.L.C. Adial Pharmaceuticals, L.L.C. Corporation true 2017 William B. Stilley, III 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22902 Executive Officer Director Joseph M. Truluck 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Executive Officer James K. Anderson 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Robertson H. Gilliland 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Bankole A. Johnson 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director James W. Newman, Jr. 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Kevin Schuyler, CFA 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Tony Goodman 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Pharmaceuticals Decline to Disclose 06b false 2018-02-23 false true true true Includes $100,000 of prior debt that exchanged for the debt and warrants false 0 500000 500000 0 false 7 0 0 0 true *Proceeds may be used to pay overhead and other corporate expenses which could include salaries false ADIAL PHARMACEUTICALS, INC. /s/ William B. Stilley, III William B. Stilley, III Chief Executive Officer 2018-03-12